1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
|
Generic Name |
Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
|---|---|---|---|
| Onasemnogene | Zolgensma | Cellular and gene therapy | 2021/02/04 |
| Patiromer | Veltassa | Potassium binder | 2020/03/09 |
| Ponesimod | Ponvory | Sphingosine 1-phosphate receptor modulator | 2021/04/28 |
| Ribociclib | Kisqali | Antineoplastic agent | 2018/11/26 |
| Satralizumab | Enspryng | Immunosuppresant | 2020/08/26 |
| Semaglutide | Rybelsus | Incretin mimetic | 2020/04/19 |
| Siponimod | Mayzent | Immunomodulatory agent | 2020/04/24 |
| Sodium zirconium cyclosilicate | Lokelma | Potassium binder | 2019/10/17 |
| Sonidegib | Odomzo | Antineoplastic agent | 2020/06/11 |
| Sumatriptan + naproxen | Suvexx | Serotonin receptor agonist + NSAID | 2020/07/24 |
| Tafamidis | Vyndaqel | Selective stabilizer of transthyretin - cardiac drug | 2020/04/07 |
| Tenapanor | Ibsrela | Sodium/hydrogen exchanger inhibitor | 2020/11/23 |
| Tepotinib | Tepmetko | Protein kinase inibitor (antineoplastic agent) | |
| Teriparatide | Osnuvo | Bone formation agent | 2020/10/27 |
| Tibolone | Tibella | Hormone replacement therapy | 2020/07/29 |
| Trastuzumab deruxtecan | Enhertu | Antineoplastic agent | 2021/04/15 |
| Tucatinib | Tukysa | Antineoplastic agent | 2020/10/08 |
| Ulipristal | Fibristal | Selective progesterone receptor modulator (SERM) | |
| Voretigene | Luxturna | Cellular and gene therapy | 2020/10/13 |
| Warfarin | Coumadin | Anticoagulant | 2020/04/23 |
| White birch extract (Betula verrucosa) | Itulatek | Allergy immunotherapy | 2020/09/28 |